Hemodynamics During Induction of General Anesthesia With Medium or Low

Status Completed

Clinical Trial Summary

In this trial the investigators want to examine if there is any difference in hemodynamic stability during induction when comparing two low and a medium remifentanil dose and keeping propofol induction dose at about 2.0 mg/kg.

Clinical Trial Description

Typically, one or more adjuvant medications is administered during induction of general anesthesia. When anesthetic drugs are combined, the hypnotic effects are often synergistic. Propofol is associated with hypotension and bradycardia and used together with remifentanil or sedative agents it may give synergistic or additive sedative and hemodynamic effects. Remifentanil is infused at 0.05-0.3 microg/kg/min during induction of anesthesia. Some use a loading dose of 0.5-1.0 microg/kg before starting the continuous infusion. The onset of action of remifentanil is within one to two minutes and it reaches rapidly a steady state effect site concentration after a bolus dose. Kazmaier (2000) showed that a high-dose remifentanil anesthesia (2 microg/kg/min) reduced cardiac index (-25%), stroke volume (-14%) and mean arterial blood pressure (-39%) in a similar manner as propofol/remifentanil (propofol target 2 microg/ml and remifentanil 0.5 microg/kg/min), but systemic vascular resistance index decreased (-14%) in propofol/remifentanil combination. Fairfield et al have earlier (1991) showed that propofol 2.5 mg/kg induction without opioid reduces cardiac output (-15%) stroke volume (-5 %), mean arterial pressure (-33%) and systemic vascular resistance (-11%) and a slight reduction i heart rate. Guarracino (2003) suggests the reduction in cardiac index during induction with propofol/remifentanil with a low propofol target (1.2 microg/ml) may be due to decreased heart rate. Zaballos (2009) have shown that remifentanil depresses sinus node and atrioventricular (AV) -nodal function in comparison with propofol alone in a closed chest porcine model. Hayashi (2016) states that even in a low remifentanil effect site concentration (3.5 nanog/ml) it may reduce heart rate significantly when combined with propofol bolus 30-50 mg. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03861377
Study type	Interventional
Source	Helse Fonna
Contact
Status	Completed
Phase	Phase 4
Start date	June 9, 2020
Completion date	February 2, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03653910` - Effect-site Concentration of Remifentanil for Double-lumen Tubes Intubation: Airtraq VS Macintosh Laryngoscope	N/A
Completed	`NCT06000098` - Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
Recruiting	`NCT02565251` - Volemic Resuscitation in Sepsis and Septic Shock	N/A
Terminated	`NCT02365688` - Hemodynamic Response During Goal Directed Fluid Therapy in the OR	N/A
Completed	`NCT01605279` - Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns	Phase 2
Completed	`NCT01559675` - Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery	N/A
Recruiting	`NCT04010058` - Postoperative Continuous Non-invasive Haemodynamic Monitoring on the Ward	N/A
Completed	`NCT06268275` - Comparison of Effects of Scalp Block and Intravenous Esmolol on Hemodynamic Response Following the Skull Pins Application for Elective Supratentorial Craniotomy	N/A
Recruiting	`NCT04926220` - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting	`NCT05003011` - Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire
Completed	`NCT03599440` - Effect of Extended Infusion Lines on Pulse Contour-based Measurements
Completed	`NCT05035485` - Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe Preeclampsia	N/A
Not yet recruiting	`NCT04227821` - Hemodynamic Optimalization in Pediatric Patients
Completed	`NCT06158165` - Evaluating The Cardiovascular Effects of Tourniquet Application
Completed	`NCT05481047` - Prevention or Treatment of Arterial Hypotension and Oxygen Cerebral Saturation During Major Abdominal Surgery	N/A
Not yet recruiting	`NCT04076709` - Cardiovascular Effects of Muscle Relaxation During Laparoscopic Surgery	Phase 4
Completed	`NCT04089098` - VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
Not yet recruiting	`NCT03828032` - Multi-parameters'Change Process During Dehydration Therapy on Brain Edema Patients.	N/A
Recruiting	`NCT05570682` - Manually Controlled Infusion vs Target Controlled Infusion for StrokeThrombectomy	N/A
Completed	`NCT04574908` - A Pilot Trial of Continuous Portable Postoperative Hemodynamic And Saturation Monitoring On Hospital Wards	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses. — RH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms